MMP2 and liver cancer: Kohga et al. found that silencing CD133 could significantly reduce the expression of MMP2 in hepatoma cells, thereby increasing the expression of MICA on the cell membrane surface and reducing the production of sMICA, suggesting that metalloproteinases are directly involved in the immune escape against NK cells in liver cancer [52].